Leukemia Journal Citation Rate 2026
0887-6924
eISSN 1476-5551
Springer Nature
GB
Q1 Quartile Top Tier
About Leukemia
Leukemia (L) is a peer-reviewed academic journal covering Acute Lymphoblastic Leukemia research and Acute Myeloid Leukemia Research, published by Springer Nature in GB, catalogued under ISSN 0887-6924 (e-ISSN 1476-5551). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 5.73 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$4790 USD). OpenAlex records 11,766 works and 633,307 citations, with an h-index of 258.
Leukemia Citation Rate 2026 — In Context
Leukemia has a 2025 2-Year Citation Rate (OpenAlex) of 5.73, placing it in the Q1 quartile within the Acute Lymphoblastic Leukemia research research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Leukemia operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Leukemia should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Leukemia against similar journals in the field, use our journal comparison tool.
Submission Tips for Leukemia
- Budget $4790 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Leukemia Compares
Compared against 22 journals in the same research areas.
| ISSN (Print) | 0887-6924 |
|---|---|
| ISSN (Online) | 1476-5551 |
| Publisher | Springer Nature |
| Country | United Kingdom |
| APC / Cost | $4790 USD |
In-depth profile & metrics
Leukemia is published by Springer Nature and based in United Kingdom. It runs on a subscription or hybrid model with an article-processing charge of USD 4790.
In our subject taxonomy, Leukemia is classified under Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research and Chronic Myeloid Leukemia Treatments.
Leukemia is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 5.731.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Leukemia
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 5.731 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare Leukemia against similar publications in its field:
Related Journals in Your Field
-
Modern Pathology Elsevier BV IF 5.84
-
American Journal of Hematology Wiley IF 4.50
-
Blood Advances Elsevier BV IF 4.44
-
Bone Marrow Transplantation Springer Nature IF 2.73
-
HemaSphere Wolters Kluwer IF 2.66
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S149476849
Get weekly updates for Acute Lymphoblastic Leukemia research journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.